Page last updated: 2024-11-02

pentoxifylline and Hematologic Malignancies

pentoxifylline has been researched along with Hematologic Malignancies in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
List, AF1
Maziarz, R1
Stiff, P1
Jansen, J1
Liesveld, J1
Andrews, F1
Schuster, M1
Wolff, S1
Litzow, M1
Karanes, C1
Dahlberg, S1
Kirkhart, B1
Bianco, JA1
Singer, JW1

Trials

1 trial available for pentoxifylline and Hematologic Malignancies

ArticleYear
A randomized placebo-controlled trial of lisofylline in HLA-identical, sibling-donor, allogeneic bone marrow transplant recipients. The Lisofylline Marrow Transplant Study Group.
    Bone marrow transplantation, 2000, Volume: 25, Issue:3

    Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Combined Chemotherapy Protocols; Beha

2000